Inventor · disambiguated record
Jay A. White
Also filed as: WHITE JAY · WHITE JAY A
30 granted patents·8 pending applications·352 citations·filing 1996–2023
97Inventor score
Files withOPKO IRELAND GLOBAL HOLDINGS LTD12CYTOCHROMA INC6UNIV KINGSTON5OPKO RENAL LLC4EIRGEN PHARMA LTD3
Top patents by PatentIndex Score
38 records- 0196US9498486B1Method for controlled release oral dosage of a vitamin D compoundOPKO RENAL LLC·Filed 2016·Granted Nov 22, 2016·18 cites·30 claims
- 0296US8778373B2Methods for controlled release oral dosage of a vitamin D compoundCYTOCHROMA INC·Filed 2013·Granted Jul 15, 2014·31 cites·20 claims
- 0396US8361488B2Methods and compositions for controlled release oral dosage of a vitamin D compoundCYTOCHROMA INC·Filed 2008·Granted Jan 29, 2013·45 cites·29 claims
- 0495US10220047B2Adjunctive therapy with 25-hydroxyvitamin D and articles thereforOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2015·Granted Mar 5, 2019·16 cites·43 claims
- 0595US9408858B2Method for treating secondary hyperparathyroidism in CKDOPKO RENAL LLC·Filed 2015·Granted Aug 9, 2016·18 cites·22 claims
- 0695US8207149B2Method for treating secondary hyperparathyroidism in CKDTABASH SAMIR P·Filed 2011·Granted Jun 26, 2012·50 cites·11 claims
- 0794US9861644B2Stabilized modified release vitamin D formulation and method of administering sameOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2014·Granted Jan 9, 2018·20 cites·36 claims
- 0893US10493084B2Adjunctive therapy with 25-hydroxyvitamin D and articles thereforOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2019·Granted Dec 3, 2019·10 cites·22 claims
- 0992US10357502B2Stabilized modified release vitamin D formulation and method of administering sameOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2018·Granted Jul 23, 2019·8 cites·29 claims
- 1092US10350224B2Stabilized modified release vitamin D formulation and method of administering sameOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2017·Granted Jul 16, 2019·8 cites·26 claims
- 1192US10300078B2Stabilized modified release vitamin D formulation and method of administering sameOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2018·Granted May 28, 2019·8 cites·28 claims
- 1290US9918940B2Methods for controlled release oral dosage of a vitamin D compoundOPKO RENAL LLC·Filed 2014·Granted Mar 20, 2018·9 cites·17 claims
- 1390US6982258B2Low-calcemic oxime analogs of 1α,25-dihydroxy vitamin D3UNIV JOHNS HOPKINS·Filed 2002·Granted Jan 3, 2006·66 cites·42 claims
- 1487US11253528B2Stabilized modified release Vitamin D formulation and method of administering sameOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2019·Granted Feb 22, 2022·1 cites·11 claims
- 1587US7166585B224-Sulfur-substituted analogs of 1α,25-dihydroxy vitamin D3UNIV JOHNS HOPKINS·Filed 2003·Granted Jan 23, 2007·23 cites·20 claims
- 1686US11154509B2Methods for controlled release oral dosage of a vitamin D compoundOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2017·Granted Oct 26, 2021·1 cites·17 claims
- 1783US11007205B2Adjunctive therapy with 25-hydroxyvitamin D and articles thereforOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2019·Granted May 18, 2021·2 cites·24 claims
- 1879US12478631B2Stabilized modified release vitamin D formulation and method of administering sameEIRGEN PHARMA LTD·Filed 2022·Granted Nov 25, 2025·0 cites·21 claims
- 1975US11738033B2Adjunctive therapy with 25-hydroxyvitamin D and articles thereforEIRGEN PHARMA LTD·Filed 2021·Granted Aug 29, 2023·0 cites·24 claims
- 2072US11672809B2Methods and compositions for reducing parathyroid levelsMESSNER ERIC J·Filed 2011·Granted Jun 13, 2023·1 cites·11 claims
- 2172US2023346804A1Methods and compositions for reducing parathyroid levelsEIRGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 2269US7115558B2P450RAI-2(P450 Cytochrome 26B), encoding nucleic acid molecules and methods and uses thereofCYTOCHROMA INC·Filed 2001·Granted Oct 3, 2006·4 cites·6 claims
- 2366US2010203511A1Retinoid metabolizing proteinUNIV KINGSTON·Filed 2008·Application pending·0 cites
- 2465US9925147B2Method for treating secondary hyperparathyroidism in CKDOPKO RENAL LLC·Filed 2016·Granted Mar 27, 2018·0 cites·98 claims
- 2565US7473422B2Antibodies to retinoid metabolizing proteinUNIV KINGSTON·Filed 2004·Granted Jan 6, 2009·0 cites·16 claims
- 2665US7335484B2Retinoid metabolizing proteinUNIV KINGSTON·Filed 2004·Granted Feb 26, 2008·0 cites·36 claims
- 2761US8106035B225-SO2-substituted analogs of 1μ,25-dihydroxyvitamin D3POSNER GARY H·Filed 2003·Granted Jan 31, 2012·3 cites·21 claims
- 2860US2018021354A1Adjunctive Therapy With 25-Hydroxyvitamin D and Articles ThereforOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2017·Application pending·0 cites
- 2959US2020253988A1Adjunctive therapy with 25-hydroxyvitamin dOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2020·Application pending·0 cites
- 3058US2010008902A1P450rai-2 (p450 cytochrome 26b), encoding nucleic acid molecules and methods and uses thereofCYTOCHROMA INC·Filed 2009·Application pending·0 cites
- 3157US7579329B2P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereofCYTOCHROMA INC·Filed 2006·Granted Aug 25, 2009·0 cites·7 claims
- 3256US6861238B1Retinoid metabolizing proteinUNIV KINGSTON·Filed 2000·Granted Mar 1, 2005·0 cites·11 claims
- 3347US7537919B2Cytochrome P450RAI-2 and related proteinsCYTOCHROMA INC·Filed 2000·Granted May 26, 2009·0 cites·39 claims
- 3442US2018085381A1Adjunctive Therapy With 25-Hydroxyvitamin DOPKO IRELAND GLOBAL HOLDINGS LTD·Filed 2015·Application pending·0 cites
- 3540US6306624B1Retinoid metabolizing proteinUNIV KINGSTON·Filed 1997·Granted Oct 23, 2001·6 cites·21 claims
- 3639US6063606ARetinoid metabolizing proteinQUEEN'S UNIVERSITY KINGSTON·Filed 1996·Granted May 16, 2000·4 cites·32 claims
- 3736US2003190642A1Thymus expressed human cytochrome p450(p450tec)Filed 2001·Application pending·0 cites
- 3834US2003149005A124-sulfur-substituted analogs of 1alpha, 25-dihydroxy vitamin D3Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jay A. White files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →